Gamma light and sound therapy for Alzheimer’s disease
Can gamma light and sound stimulation slow Alzheimer's disease or delay dementia in cognitively normal people at risk?
The research spans treatment of Alzheimer's disease and prevention in people at risk. Following both directions could clarify whether this sensory approach offers meaningful benefits and who might benefit.
Where it stands now
Main bottleneck
Establishing whether repeated gamma light and sound stimulation delivers lasting clinical benefits, with treatment and prevention requiring separate evidence.
Watch next
Human trial results showing whether stimulation preserves cognition in people with Alzheimer's disease or reduces progression toward dementia in cognitively normal people at risk, alongside safety findings.
Progress timeline
How the evidence has changed over time.
2023 · 1 update
- Why daily light and sound is being tested in people with normal memory at Alzheimer's riskResearch note 2 of 2 · Source date 2023-03-20
Since the previous research note · Earlier expectation not tested
Track continuity
Since the previous research note: What six months of home light and sound therapy could reveal about Alzheimer’s disease
Previous expectation: Sustained home light and sound stimulation might become a practical treatment for people with Alzheimer's disease if it produced meaningful cognitive benefit with acceptable safety and manageable daily use.
What this study adds: The supplied registry description addresses a prevention question in people with normal memory, family history and cerebral amyloid deposits, using a described 12-month home regimen. It does not supply outcome evidence testing the earlier treatment forecast.
Current research note
2022 · 1 update
- What six months of home light and sound therapy could reveal about Alzheimer’s diseaseResearch note 1 of 2 · Source date 2022-12-19
How this Track works
This page changes as new evidence arrives. Open any update to see what researchers found at that point in the story.